510(k) Report

510(k) · Cleared

Cleared

MyOnyx System

K213197510(k) TraditionalCleared Jun 17, 2022261-day reviewClass II21 CFR 890.5850

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Thought Technology, Ltd. · IPF Stimulator, Muscle, Powered

Cleared on Jun 17, 2022 as substantially equivalent to K171978 (Shenzhen Dongdixin Technology Co., Ltd., 2017) after a 261-day review. Its family tree reaches back 4 generations to 1999.

Decided
Jun 17, 2022
Review
261 days
Class
Class II
Product code
IPF
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K984142 (1999). 5 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 4 generations backK984142 Sonicator Plus 992, Model Number ME 992 and Sonicator Plus 994…Mettler Electronics Corp. · 1999
  2. 3 generations backK071137 Sonicator Plus 940, Model ME940Mettler Electronics Corp. · 2007
  3. 2 generations backK093138 MT9000 Series Electro-Stimulator, Models MT9000, MT9002, MT9001…Shenzhen Dongdixin Technology Co., Ltd. · 2010 · Recalled
  4. 1 generation backK171978 Combo Stimulator MT9000, Combo Stimulator LT7102, TENS Stimulator…Shenzhen Dongdixin Technology Co., Ltd. · 2017
  5. This deviceK213197 MyOnyx SystemThought Technology, Ltd. · 2022
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K984142Sonicator Plus 992, Model Number ME 992 and Sonicator Plus 994, Model Number…Mettler Electronics Corp.1999—
−3K071137Sonicator Plus 940, Model ME940Mettler Electronics Corp.2007—
−2K093138MT9000 Series Electro-Stimulator, Models MT9000, MT9002, MT9001, MT9004 and…Shenzhen Dongdixin Technology Co., Ltd.20101
−1K171978Combo Stimulator MT9000, Combo Stimulator LT7102, TENS Stimulator InTENSity 10Shenzhen Dongdixin Technology Co., Ltd.2017—
0 (this device)K213197MyOnyx SystemThought Technology, Ltd.2022—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200310
FIG. 1 — Lineage of K213197, 1999–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in IPF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new IPF device

  1. #1 K241433 EVE Synergy (EVE-20M)score 19.7 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K171978Combo Stimulator MT9000, Combo Stimulator LT7102, TENS Stimulator InTENSity 10
Summary page 4
…ectiveness information to provide an understanding of the basis for a determination of substantial equivalence. Predicate Device: Combo Stimulator MT9000 (K171978, Product Codes: IPF, GZJ) Reference Device: MyOnyx System (K201014, Product codes: KPI, HCC) Indications for Us…
Shenzhen Dongdixin Technology Co., Ltd.2017—
†K201014MyOnyx SystemThought Technology, Ltd.2021—
†K132422Pals Platinum Neurostimulation ElectrodesAxelgaard Mfg. Co., Ltd.2014—

Also cleared against K171978: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 3 companies; a new generation was cleared every 7.6 years on median.
  • 2 of the 5 ancestors have a recall of any class.
  • 1 other device also cites its predicate K171978.

How does its category compare?

All IPF devices

IPF Stimulator, Muscle, Powered: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · IPF

3in 2025

2007: 82008: 62009: 72010: 42011: 42012: 42013: 102014: 42015: 32016: 72017: 52018: 52019: 42020: 92021: 152022: 72023: 92024: 72025: 32026 (partial year): 3
2007high 15 (2021) · low 3 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · IPF

257in 2025

2007: 143 days median2008: 140 days median2009: 216 days median2010: 121 days median2011: 275 days median2012: 269 days median2013: 180 days median2014: 264 days median2015: 43 days median2016: 113 days median2017: 110 days median2018: 73 days median2019: 133 days median2020: 121 days median2021: 98 days median2022: 108 days median2023: 255 days median2024: 201 days median2025: 257 days median2026 (partial year): 206 days median
2007high 275 (2011) · low 43 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · IPF

1in 2023

2008: 12011: 12012: 32023: 1
2007high 3 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · IPF

8in 2025

2007: 112008: 2132009: 1502010: 142011: 252012: 162013: 62014: 192015: 112016: 82017: 22018: 32019: 102020: 132021: 32022: 42023: 82024: 52025: 8
2007high 213 (2008) · low 2 (2017)2025

MAUDE reports naming product code IPF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078143011
200861401213
200972160150
20104121014
20114275125
20124269316
20131018006
20144264019
2015343011
2016711308
2017511002
201857303
20194133010
20209121013
2021159803
2022710804
2023925518
2024720105
2025325708
202632060—

What is it indicated for?

The MyOnyx System is intended for use as a powered muscle stimulation device for relaxation of muscle spasms and muscle re-education, prevention or retardation of disuse atrophy, maintaining or increasing range of motion, increasing local blood circulation, and immediate post-surgical stimulation of calf muscles to prevent venous thrombosis.

The MyOnyx System may also be used for transcutaneous electrical nerve stimulation (TENS) and microcurrent electrical stimulation (MET) for the symptomatic relief of acute and chronic intractable pain.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K213197: MyOnyx System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K213197

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026